Metabolic traits affecting the relationship between liver fat and intrapancreatic fat: a mediation analysis
Open Access
- 4 October 2022
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 66 (1) , 190-200
Abstract
Aims/hypothesis: The clinical importance of fat deposition in the liver and pancreas is increasingly recognised. However, to what extent deposition of fat in these two depots is affected by intermediate variables is unknown. The aim of this work was to conduct a mediation analysis with a view to uncovering the metabolic traits that underlie the relationship between liver fat and intrapancreatic fat deposition (IPFD) and quantifying their effect. Methods: All participants underwent MRI/magnetic resonance spectroscopy on the same 3.0 T scanner to determine liver fat and IPFD. IPFD of all participants was quantified manually by two independent raters in duplicate. A total of 16 metabolic traits (representing markers of glucose metabolism, incretins, lipid panel, liver enzymes, pancreatic hormones and their derivatives) were measured in blood. Mediation analysis was conducted, taking into account age, sex, ethnicity and BMI. Significance of mediation was tested by computing bias-corrected bootstrap CIs with 5000 repetitions. Results: A total of 353 individuals were studied. Plasma glucose, HDL-cholesterol and triacylglycerol mediated 6.8%, 17.9% and 24.3%, respectively, of the association between liver fat and IPFD. Total cholesterol, LDL-cholesterol, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, γ-glutamyl transpeptidase, insulin, glucagon, amylin, C-peptide, HbA1c, glucagon-like peptide-1 and gastric inhibitory peptide did not mediate the association between liver fat and IPFD. Conclusions/interpretation: At least one-quarter of the association between liver fat and IPFD is mediated by specific blood biomarkers (triacylglycerol, HDL-cholesterol and glucose), after accounting for potential confounding by age, sex, ethnicity and BMI. This unveils the complexity of the association between the two fat depots and presents specific targets for intervention. GraphicalKeywords
Funding Information
- Royal Society Te Apārangi (Rutherford Discovery Fellowship)
This publication has 51 references indexed in Scilit:
- Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and NonrespondersDiabetes Care, 2016
- Pancreatic Fat Accumulation, Fibrosis, and Acinar Cell Injury in the Zucker Diabetic Fatty Rat Fed a Chronic High-Fat DietPancreas, 2014
- Fatty Pancreas, Insulin Resistance, and β-Cell Function: A Population Study Using Fat-Water Magnetic Resonance ImagingAmerican Journal of Gastroenterology, 2014
- Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerolDiabetologia, 2011
- A prospective evaluation of fatty pancreas by using EUSGastrointestinal Endoscopy, 2011
- Associated factors for a hyperechogenic pancreas on endoscopic ultrasoundWorld Journal of Gastroenterology, 2010
- Beyond Baron and Kenny: Statistical Mediation Analysis in the New MillenniumCommunication Monographs, 2009
- Clinical implications of fatty pancreas: Correlations between fatty pancreas and metabolic syndromeWorld Journal of Gastroenterology, 2009
- Pathogenesis of type 2 diabetes: tracing the reverse route from cure to causeDiabetologia, 2008
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡Hepatology, 2006